Consistent with our previous studies, βII-, βIII-, and βIVb-tubulin siRNA potently inhibited protein expression of each of these targets respectively without affecting the expression of other major β-tubulin isotypes in the NSCLC cell lines (Figure S1) [15], [16]. The gene discussed is CACNA1B; the disease is non-small cell lung carcinoma.